HUMAN DRUG CGMP NOTES March 1999
...The CGMP regulations allow for the use of accelerated stability studies to project a tentative.....Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....Should investigators cite firms for not conducting accelerated stability testing during..
http://www.fda.gov/cder/hdn/cnotes39.htm (score=100)
Human Drug Notes
...drug product, stability studies should be conducted according to an approved stability protocol to.....In the latter case, until appropriate stability data is generated, the expiration date.....Should sterile drug process inspections continue to focus on sterile filtration validation..
http://www.fda.gov/cder/hdn/hdn1295.htm (score=88)
Guidance for Industry: Q1F Stability Data Package for Registration...
...No intermediate storage condition for stability studies is recommended for climatic zones.....pharmaceutical products containing well established drug substances in conventional dosage.....condition for stability testing of a new drug substance or drug product for a registration..
http://www.fda.gov/cber/gdlns/ichclmzns.pdf (score=64)
Packaging
...Samples of a drug that are selected for stability studies should be packaged in the container/clsoure system in which the drug.....In these early stages, the IND should also indicate that appropriate stability studies with the.....Arthur Shaw, Food and Drug Administration, for a Course offered by the Center for..
http://www.fda.gov/cder/guidance/package.htm (score=64)
...FDA's current guidance for industry states that data accumulated from ongoing stability studies.....Submit two copies of the annual progress report of postmarketing studies to the Food and Drug Administration.....Therefore, it is clear from existing regulations and guidance that stability studies are..
http://www.fda.gov/OHRMS/DOCKETS/98fr/103000c.htm (score=64)
...For example, these data can be obtained from studies on one batch of drug product conducted for up to 3 months at.....Guidance for Industry Q1F Stability Data Package for Registration Applications in Climatic.....Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug..
http://www.fda.gov/cder/guidance/6312fnl.doc (score=64)
þÿ
...No intermediate storage condition for stability studies is recommended for climatic zones.....pharmaceutical products containing well established drug substances in conventional dosage.....condition for stability testing of a new drug substance or drug product for a registration..
http://www.fda.gov/cder/guidance/6312fnl.pdf (score=64)
Human Drug Notes
...Where an expiration dating period is derived from stability studies conducted on the repackaged drug.....Welcome to the first edition of our fourth year of Human Drug CGMP Notes, our periodic.....stability studies. Any extension of the expiration dating should be of sufficient duration..
http://www.fda.gov/cder/hdn/hdn396.htm (score=53)
Format and Content for the CMC Section of an Annual Report
...the design of stability protocols, the amount of stability data that should be provided to.....Regulatory specifications and analytical methods for the drug substance and drug..product should be listed.....changed container and closure system in stability studies using the..approved stability..
http://www.fda.gov/cder/guidance/cmc1.pdf (score=53)
Microsoft Word - 5666fnl.doc
...for that product based on acceptable data from full, long-term stability studies on at.....Previously, two approaches have been used to extend the shelf life of expired drug.....8 In June 1998, the Agency issued a draft guidance on stability testing, Stability Testing of Drug Substances..
http://www.fda.gov/cder/guidance/5666fnl.pdf (score=41)
...DISCUSSION Studies conducted during the SLEP program on a variety of drug products have.....Observations About KI Tablet Stability Based on Historical Data Potassium Iodide Tablets.....Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and..
http://www.fda.gov/cder/guidance/5666fnl.doc (score=41)
Guidance for Industry
...adverse drug experience, which is required to be reported to the Food and Drug.....provided that they meet appropriate standards or specifications as demonstrated by.....There must be a written testing program designed to assess the stability characteristics..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03d-0165-gdl0001.pdf (score=40)
MDI and DPI Drug Products
...For MDI and DPI drug products, certain studies should be performed to determine.....manufacturing, processing, packaging, controls, stability testing, or labeling operations.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=30)
HUMAN DRUG CGMP NOTES June 1966
...used in the delivery of a medical drug product is considered an integral part of the drug.....Where stability testing reveals that the BPC is stable for the intended period of use, or.....stability studies have been conducted through a limited time only (e.g., in either case less than..
http://www.fda.gov/cder/hdn/hdn696.htm (score=29)
HUMAN DRUG CGMP NOTES June 1998
...If the kits contain drugs that are subject to the new drug provisions in the Food Drug and Cosmetic Act, the sterile.....FDA expects the validation studies will be completed in accordance with written protocols.....166, Stability testing, and 211.167, Special testing requirements; Compliance Policy Guide..
http://www.fda.gov/cder/hdn/cnotes68.htm (score=29)
Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date
...Similarly, the primary stability studies submitted in support of the application should be performed.....The notice stated that after August 14, 2000, any orally administered drug product.....Primary stability data should be generated according to guidance developed by the..
http://www.fda.gov/cder/guidance/4647fnl.htm (score=29)
þÿ
...Similarly, the primary stability studies submitted in support of the application should be.....The notice stated that after August 14, 2000, any orally administered drug product.....1 This guidance has been prepared by the Office of Regulatory Policy in the Center for..
http://www.fda.gov/OHRMS/DOCKETS/98fr/970314gd.PDF (score=29)
Guidance for Industry: Monoclonal Antibodies Used as Reagents in Drug...
...The mAb manufacturer should perform real-time stability studies of unconjugated and.....2 The term drug substance, which is used throughout the text, is intended to include.....supporting the in-use chemical stability of the column and mAb reagent using the..
http://www.fda.gov/cber/gdlns/mab032901.pdf (score=29)
March/April 1997 FDA Veterinarian Newsletter
...Veterinarians rarely have the ability to establish drug stability, physical and chemical.....When well-controlled clinical studies are lacking we must use more tenuous supportive.....Are there any additional conditions that must be met to use either a human drug or an animal drug that has..
http://www.fda.gov/cvm/index/fdavet/1997/march.htm (score=28)
Guidance for Industry Q1F Stability Data Package for
...No intermediate storage condition for stability studies is recommended for climatic zones III and IV.....For example, these data can be obtained from studies on one batch of drug product conducted for up to 3 months at.....Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug..
http://www.fda.gov/cder/guidance/6312fnl.htm (score=28)
Powered by viXML, providing custom search results
Las Vegas Injury Lawyer